Tonix Pharmaceuticals has launched Tonmya (cyclobenzaprine), a newly approved oral treatment for adults with fibromyalgia.

Here’s what to look for in a fibromyalgia care provider to ensure you get the most compassionate, collaborative treatment.

Researchers and patients are calling for the NHS to overhaul its care of fibromyalgia patients.

In a milestone moment for chronic pain management, Tonix Pharmaceuticals announced on August 15, 2025, that its novel ...

Discover the National Fibromyalgia Association's mission to enhance life for people with fibromyalgia through awareness, education, support, and advocacy efforts.

TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonmya™ Commercial Launch Underway Following the approval of Tonmya™ ...

The New Bedford Science Cafe will host a discussion on a new FDA-approved fibromyalgia drug from 6 to 8 p.m. Dec. 2 at The Last Round Bar & Grille, 908 Purchase St., New Bedford. Seth Lederman, MD, ...

A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured seven in 10 type 2 ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Approximately 43% of patients aged 65 years or older with rheumatic disease filled at least one opioid prescription in 2021, ...

Ms. Ishak brings more than 25 years of corporate legal and strategic leadership experience in the life sciences industry ...

Australian scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to ...